Psoriasis is characterized by accumulation of immunostimulatory and Th1/Th17 cell-polarizing myeloid dendritic cells.

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Journal of Investigative Dermatology

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/jid.2008.194PMID 18633443PMCID PMC2701224
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The sphingosine 1-phosphate receptor 1 causes tissue retention by inhibiting the entry of peripheral tissue T lymphocytes into afferent lymphatics

  2008cited by this paper
• Psoriasis vulgaris lesions contain discrete populations of Th1 and Th17 T cells.

  2008cited by this paper
• Selective blockade of the inhibitory Fcγ receptor (FcγRIIB) in human dendritic cells and monocytes induces a type I interferon response program

  2007cited by this paper
• Interleukin-22, a TH17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis

  2007cited by this paper
• Pathogenesis and therapy of psoriasis

  2007cited by this paper
• Immunosurveillance by hematopoietic progenitor cells trafficking through blood, lymph, and peripheral tissues.

  2007influential reference
• Selective blockade of the inhibitory Fcγ receptor (FcγRIIB) in human dendritic cells and monocytes induces a type I interferon response program

  2007cited by this paper
• Amelioration of epidermal hyperplasia by TNF inhibition is associated with reduced Th17 responses

  2007influential reference
• CD1 antigen presentation: how it works

  2007cited by this paper
• Origin of dendritic cells in peripheral lymphoid organs of mice

  2007cited by this paper
• Quantification of dendritic cell subsets in human renal tissue under normal and pathological conditions.

  2007cited by this paper
• IL-17 family cytokines and the expanding diversity of effector T cell lineages.

  2007cited by this paper
• Normal human dermis contains distinct populations of CD11c+BDCA-1+ dendritic cells and CD163+FXIIIA+ macrophages.

  2007influential reference
• Immunopathogenesis and role of T cells in psoriasis.

  2007cited by this paper
• New concepts in the pathogenesis and treatment of psoriasis: key roles for IL-23, IL-17A and TGF-β1

  2007cited by this paper
• CD 163 positive subsets of blood dendritic cells : The scavenging macrophage receptors CD 163 and CD 91 are coexpressed on human dendritic cells and monocytes

  2006cited by this paper
• The number and distribution of blood dendritic cells in the epidermis and dermis of healthy human subjects.

  2006cited by this paper
• Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides

  2006cited by this paper
• Identification of a radio-resistant and cycling dermal dendritic cell population in mice and men

  2006cited by this paper
• CD163 positive subsets of blood dendritic cells: the scavenging macrophage receptors CD163 and CD91 are coexpressed on human dendritic cells and monocytes.

  2006cited by this paper
• Migratory fate and differentiation of blood monocyte subsets.

  2006cited by this paper
• Prominent production of IL-20 by CD68+/CD11c+ myeloid-derived cells in psoriasis: Gene regulation and cellular effects.

  2006influential reference
• TNF Inhibition Rapidly Down-Regulates Multiple Proinflammatory Pathways in Psoriasis Plaques1

  2005cited by this paper
• Dendritic Cell-Specific Intercellular Adhesion Molecule 3-Grabbing Nonintegrin/CD209 Is Abundant on Macrophages in the Normal Human Lymph Node and Is Not Required for Dendritic Cell Stimulation of the Mixed Leukocyte Reaction1

  2005cited by this paper
• Plasmacytoid predendritic cells initiate psoriasis through interferon-α production

  2005cited by this paper
• Increase in TNF-alpha and inducible nitric oxide synthase-expressing dendritic cells in psoriasis and reduction with efalizumab (anti-CD11a).

  2005influential reference
• Increased Expression of Interleukin 23 p19 and p40 in Lesional Skin of Patients with Psoriasis Vulgaris

  2004cited by this paper
• Psoriasis vulgaris: cutaneous lymphoid tissue supports T-cell activation and "Type 1" inflammatory gene expression.

  2004cited by this paper
• Dendritic cells and immunity to Listeria: TipDCs are a new recruit.

  2004cited by this paper
• TNF/iNOS-producing dendritic cells mediate innate immune defense against bacterial infection.

  2003cited by this paper
• Characterization of human blood dendritic cell subsets.

  2002influential reference
• A clinical grade cocktail of cytokines and PGE2 results in uniform maturation of human monocyte-derived dendritic cells: implications for immunotherapy.

  2002cited by this paper
• The CD16+ (FcγRIII+) Subset of Human Monocytes Preferentially Becomes Migratory Dendritic Cells in a Model Tissue Setting

  2002cited by this paper
• CTLA4Ig-mediated blockade of T-cell costimulation in patients with psoriasis vulgaris.

  1999cited by this paper

• Programmed cell death of keratinocytes: an active driver in psoriasis

  2026cites this paper
• Systemic Psoriasis: From Molecular Mechanisms to Global Management Strategies

  2025cites this paper
• Advances in Psoriasis Research: Decoding Immune Circuits and Developing Novel Therapies

  2025cites this paper
• Skin immune microenvironment in psoriasis: from bench to bedside

  2025cites this paper
• The Role of TNF - α, IFN - γ, and IL-6 in Guiding Treatment and Predicting Prognosis in the Treatment of Severe Plaque Psoriasis with Adalimumab

  2025cites this paper
• Skin immunity and inflammation: cellular interactions and communication

  2025cites this paper
• Psychological Stress Overactivates IL‐23/Th17 Inflammatory Axis and Increases cDC2 in Imiquimod‐Induced Psoriasis Models of C57BL/6 Mice

  2025cites this paper
• The Biology of Dendritic Cells: In Health and Disease.

  2025cites this paper
• Advancing Psoriasis Care: Efficacy of Nanosuspensions in Targeted Skin Therapies

  2025cites this paper
• Role of cGAS-STING pathway in Fibrotic Disease.

  2025cites this paper
• Drug-loaded microneedle patches containing regulatory T cell-derived exosomes for psoriasis treatment.

  2025cites this paper
• Autoimmune Skin Diseases and Survival Outcomes After Antineoplastic Treatment in Patients With Cancer.

  2025cites this paper
• Assessing T-Cell Profile Shifts through IL-23 Inhibition by Guselkumab on Psoriasis

  2025cites this paper
• Ganoderic acid A alleviate psoriasis by inhibiting GSDMD-mediated pyroptosis.

  2025cites this paper
• Parachlorella beijerinckii-derived carotenoids ameliorate inflammation in a psoriasis-like mouse model via modulation of pro-inflammatory cytokines in dendritic cells.

  2025cites this paper
• Targeting STING in dendritic cells alleviates psoriatic inflammation by suppressing IL-17A production

  2024cites this paper
• Comparative Proteomics Analysis Reveals Distinct Molecular Phenotype and Biomarkers in Patients with Erythrodermic Atopic Dermatitis and Erythrodermic Psoriasis

  2024cites this paper
• A BET inhibitor, NHWD-870, can downregulate dendritic cells maturation via the IRF7-mediated signaling pathway to ameliorate imiquimod-induced psoriasis-like murine skin inflammation.

  2024cites this paper
• Regulation of the Immune Cell Repertoire in Psoriasis Patients Upon Blockade of IL-17A or TNFα

  2024cites this paper
• Curcumin as a regulator of Th17 cells: Unveiling the mechanisms

  2024cites this paper
• Theoretical Studies of DNA Microarray Present Potential Molecular and Cellular Interconnectivity of Signaling Pathways in Immune System Dysregulation

  2024cites this paper
• The Immunology of Psoriasis—Current Concepts in Pathogenesis

  2024influential citation
• Psoriatic march: A view from pathophysiology to cardiovascular risk

  2024cites this paper
• Adenosine A2A receptor activation regulates the M1 macrophages activation to initiate innate and adaptive immunity in psoriasis.

  2024cites this paper
• Damage-Associated Molecular Patterns, a Class of Potential Psoriasis Drug Targets

  2024cites this paper
• IFN-γ, IL-17A, IL-4, and IL-13: Potential Biomarkers for Prediction of the Effectiveness of Biologics in Psoriasis Patients

  2024cites this paper
• Investigation into the molecular mechanisms of biomarkers in psoriasis vulgaris with reduced high-density lipoprotein levels based on bulk transcriptome sequencing data.

  2024cites this paper
• Inflammasomes and their roles in autoimmune diseases

  2024cites this paper
• Molecular consideration relevant to the mechanism of the comorbidity between psoriasis and systemic lupus erythematosus (Review)

  2023cites this paper
• Immune cells in skin inflammation, wound healing and skin cancer.

  2023cites this paper
• Th17 Cells: Orchestrators of Mucosal Inflammation and Potential Therapeutic Targets.

  2023cites this paper
• Inflammatory Cues Direct Skin-Resident Type 1 Innate Lymphoid Cells to Adopt a Psoriasis-Promoting Identity

  2023cites this paper
• Cellular Mechanisms of Psoriasis Pathogenesis: A Systemic Review

  2023cites this paper
• HDAC2 Inhibits Hippocampal Neurogenesis and Impairs the Cognitive Function in Prenatally Stressed Adult Offspring

  2023cites this paper
• The Potential Role of Hyperbaric Oxygen Therapy in Psoriasis Treatment: A Review of PI3K/AKT/FOXO Signaling Cascade and Interleukin-1β

  2023cites this paper
• From the Skin to Distant Sites: T Cells in Psoriatic Disease

  2023cites this paper
• A Review of Dupilumab-Induced Adverse Events to Dermatologists and the Potential Pathogenesis in the Treatment of Atopic Dermatitis

  2023cites this paper
• The Use of Microbial Modifying Therapies to Prevent Psoriasis Exacerbation and Associated Cardiovascular Comorbidity

  2023cites this paper
• Aberrant inflammasome activation as a driving force of human autoimmune skin disease

  2023cites this paper
• The Role of Oxidative Stress in the Induction and Development of Psoriasis.

  2023cites this paper
• Conventional dendritic cells type 1 are strongly enriched, quiescent and relatively tolerogenic in local inflammatory arthritis

  2023cites this paper
• From IL-17 to IFN-γ in inflammatory skin disorders: Is transdifferentiation a potential treatment target?

  2022cites this paper
• Dendritic Cells and Macrophages in the Pathogenesis of Psoriasis

  2022cites this paper
• The Dendritic Cell Dilemma in the Skin: Between Tolerance and Immunity

  2022cites this paper
• Marcha psoriásica: una mirada desde la fisiopatología hasta el riesgo cardiovascular

  2022cites this paper
• PTT_A_328575 1..14

  2022cites this paper
• A sharp decrease of Th17, CXCR3+-Th17, and Th17.1 in peripheral blood is associated with an early anti-IL-17-mediated clinical remission in psoriasis

  2022cites this paper
• Suppression of IL‐12/IL‐23 p40 subunit in the skin and blood of psoriasis patients by Tofacitinib is dependent on active interferon‐γ signaling in dendritic cells: Implications for the treatment of psoriasis and interferon‐driven diseases

  2022cites this paper
• Relationship between Immune Cells, Depression, Stress, and Psoriasis: Could the Use of Natural Products Be Helpful?

  2022cites this paper
• Peroxisome proliferator-activator receptor γ and psoriasis, molecular and cellular biochemistry

  2022cites this paper
• Psoriasis between Autoimmunity and Oxidative Stress: Changes Induced by Different Therapeutic Approaches

  2022cites this paper
• Functional specialization of specific DC subsets in the synovial fluid of JIA patients

  2022cites this paper
• Human dendritic cell subsets: An updated view of their ontogeny and functional specialization

  2022cites this paper
• Hydrogel-mediated topical delivery of steroids can effectively alleviate psoriasis via attenuating the autoimmune responses.

  2022cites this paper
• Local IL-23 is required for proliferation and retention of skin-resident memory TH17 cells

  2022cites this paper
• Biologics in Psoriasis: Updated Perspectives on Long-Term Safety and Risk Management

  2022cites this paper
• Role of innate immune system cells in psoriasis

  2022cites this paper
• ETV3 and ETV6 enable monocyte differentiation into dendritic cells by repressing macrophage fate commitment

  2022cites this paper
• Antigen-Presenting Cells in Psoriasis

  2022cites this paper
• Chrna5 is overexpressed in psoriasis patients and promotes psoriasis-like inflammation in mouse models.

  2022cites this paper
• A role for whey acidic protein four-disulfide-core 12 (WFDC12) in the pathogenesis and development of psoriasis disease

  2022cites this paper
• Pathogenesis, multi-omics research, and clinical treatment of psoriasis.

  2022cites this paper
• Extensive Phenotype of Human Inflammatory Monocyte-Derived Dendritic Cells

  2021cites this paper
• Therapeutic Development Based on the Immunopathogenic Mechanisms of Psoriasis

  2021cites this paper
• Depression and Obesity in Patients With Psoriasis and Psoriatic Arthritis: Is IL-17-Mediated Immune Dysregulation the Connecting Link?

  2021cites this paper
• Nanoemulsions: A Review on the Conceptualization of Treatment for Psoriasis Using a ‘Green’ Surfactant with Low-Energy Emulsification Method

  2021cites this paper
• MAFB surrogates the glucocorticoid receptor ability to induce tolerogenesis in dendritic cells

  2021cites this paper
• Thrombosis in Psoriasis: Cutaneous Cytokine Production as a Potential Driving Force of Haemostatic Dysregulation and Subsequent Cardiovascular Risk

  2021cites this paper
• Psoriatic skin inflammation is promoted by c‐Jun/AP‐1‐dependent CCL2 and IL‐23 expression in dendritic cells

  2021cites this paper
• Single-cell transcriptomics applied to emigrating cells from psoriasis elucidate pathogenic vs. regulatory immune cell subsets.

  2021cites this paper
• Current Understanding of the Immunomodulatory Activities of High-Density Lipoproteins

  2021cites this paper
• Single-cell Transcriptomics Uncover a Novel Role of Myeloid Cells and T-lymphocytes in the Fibrotic Microenvironment in Peyronie's Disease.

  2021cites this paper
• Role of the IL-23/IL-17 Pathway in Rheumatic Diseases: An Overview

  2021cites this paper
• Differential Changes in Inflammatory Mononuclear Phagocyte and T Cell Profiles within Psoriatic Skin during Treatment with Guselkumab versus Secukinumab.

  2021cites this paper
• Polysaccharide mycophenolate-based nanoparticles for enhanced immunosuppression and treatment of immune-mediated inflammatory diseases

  2021cites this paper
• Endoscopic Injection Treatment of Vesicoureteral Reflux in Children: Meeting with the Factors Involved in the Success Rate.

  2021influential citation
• Mitochondrial Reactive Oxygen Species Are Essential for the Development of Psoriatic Inflammation

  2021cites this paper
• Myeloid dendritic cells are major producers of interferon-β in dermatomyositis and may contribute to hydroxychloroquine refractoriness.

  2021cites this paper
• Immune responses and therapeutic options in psoriasis

  2021cites this paper
• Goeckerman Regimen Reduces Alarmin Levels and PASI Score in Paediatric Patients with Psoriasis.

  2021cites this paper
• Axial spondyloarthritis: new advances in diagnosis and management

  2021cites this paper
• Clinicoprognostic and Histopathological Features of Guttate and Plaque Psoriasis Based on PD-1 Expression

  2021cites this paper
• Use of secukinumab in erythrodermic psoriasis: A single center experience.

  2021cites this paper
• Participation of interferons in psoriatic inflammation.

  2021cites this paper
• Potential Therapeutic Approaches through Modulating the Autophagy Process for Skin Barrier Dysfunction

  2021cites this paper
• Pulmonary and blood dendritic cells from sarcoidosis patients more potently induce IFNγ‐producing Th1 cells compared with monocytes

  2021cites this paper
• Coordinated glucocorticoid receptor and MAFB action induces tolerogenesis and epigenome remodeling in dendritic cells

  2021cites this paper
• IL-30 ameliorates imiquimod and K14-VEGF induced psoriasis-like disease by inhibiting both innate and adaptive immunity disorders.

  2021cites this paper
• Therapeutics targeting the IL-23 and IL-17 pathway in psoriasis.

  2021cites this paper
• Pathogenesis of psoriasis in the “omic” era. Part I. Epidemiology, clinical manifestation, immunological and neuroendocrine disturbances

  2020cites this paper
• Psoriatic arthritis under the influence of IFNγ.

  2020cites this paper
• Shear wave elastography and microvascular ultrasound in response evaluation to calcipotriol+betamethasone foam in plaque psoriasis

  2020cites this paper
• Exosomes Derived from Human Umbilical Cord Mesenchymal Stem Cells Alleviate Psoriasis-like Skin Inflammation

  2020cites this paper
• Traitor or warrior-Treg cells sneaking into the lesions of psoriatic arthritis.

  2020cites this paper
• Trends in nanotechnology-based delivery systems for dermal targeting of drugs: an enticing approach to offset psoriasis

  2020cites this paper
• RESPIRATORY MONONUCLEAR PHAGOCYTES DURING STEADY STATE AND SARCOIDOSIS

  2020cites this paper
• Photocontrolled miR-148b nanoparticles cause apoptosis, inflammation and regression of Ras induced epidermal squamous cell carcinomas in mice.

  2020cites this paper
• Inflammatory Arthritis: Psoriatic Arthritis

  2020cites this paper
• Uptake and trafficking of different sized PLGA nanoparticles by dendritic cells in imiquimod-induced psoriasis-like mice model

  2020cites this paper
• Th17/IL-17 Axis Regulated by Airway Microbes Get Involved in the Development of Asthma

  2020cites this paper